Psychotic symptoms following synthetic opioid withdrawal: A case report

Read full text
Authors: Dr. Sanjeev Kumar Mishra, Bivek Mishra, Ramesh Sapkota, N. Sapkota, Tek Nath Yogi, Rijan Kafle, Diwakar Koirala
Cited by: 0
References: 6

Abstract

Psychosis during opioid withdrawal is rare but clinically significant and may complicate detoxification and delay accurate diagnosis, particularly with synthetic opioids such as tramadol. We report the case of a 41-year-old married male with no prior personal or family psychiatric history who developed acute psychotic symptoms following abrupt cessation of tramadol. The patient had a 25-year history of alcohol dependence but had been in sustained remission for 3.5 years. After stopping tramadol, he initially developed classical opioid withdrawal symptoms, followed several days later by second-person auditory hallucinations and persecutory delusions. On admission, the Clinical Opioid Withdrawal Scale (COWS) score was 25/60, indicating moderate to severe withdrawal. He was managed with opioid agonist substitution, benzodiazepines, and short-term antipsychotic therapy, resulting in rapid resolution of both withdrawal and psychotic symptoms. The patient was discharged symptom-free on day 11 and remained asymptomatic without recurrence during four weeks of follow-up. This case highlights tramadol withdrawal–induced psychosis as an uncommon but important clinical entity and underscores the importance of careful substance use history, close monitoring during withdrawal, and appropriate short-term antipsychotic use to avoid misdiagnosis as primary psychosis or delirium. • Psychosis can rarely emerge during withdrawal from synthetic opioids like tramadol. • Case shows persecutory delusions and auditory hallucinations after opioid cessation. • Symptoms resolved rapidly with codeine tapering and short-term antipsychotics. • Chronic alcohol history may heighten vulnerability to withdrawal-related psychosis. • Early recognition avoids misdiagnosis as primary psychosis and guides treatment.

Fields of Study & Subjects

Opioid Use Disorder Treatment Schizophrenia research and treatment Substance Abuse Treatment and Outcomes

Publication details

Journal / source
Medical Reports
Volume
16
Pages
100421–100421
Publication date
4 February 2026
Language
EN